These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21456062)

  • 1. Regulation of phosphatase homologue of tensin protein expression by bone morphogenetic proteins in prostate epithelial cells.
    Jerde TJ; Wu Z; Theodorescu D; Bushman W
    Prostate; 2011 Jun; 71(8):791-800. PubMed ID: 21456062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP-2 up-regulates PTEN expression and induces apoptosis of pulmonary artery smooth muscle cells under hypoxia.
    Pi W; Guo X; Su L; Xu W
    PLoS One; 2012; 7(5):e35283. PubMed ID: 22615735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.
    Yang S; Zhong C; Frenkel B; Reddi AH; Roy-Burman P
    Cancer Res; 2005 Jul; 65(13):5769-77. PubMed ID: 15994952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.
    Dai J; Kitagawa Y; Zhang J; Yao Z; Mizokami A; Cheng S; Nör J; McCauley LK; Taichman RS; Keller ET
    Cancer Res; 2004 Feb; 64(3):994-9. PubMed ID: 14871830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.
    Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET
    Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling.
    Wahdan-Alaswad RS; Song K; Krebs TL; Shola DT; Gomez JA; Matsuyama S; Danielpour D
    Cancer Res; 2010 Nov; 70(22):9106-17. PubMed ID: 21062988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP suppresses PTEN expression via RAS/ERK signaling.
    Beck SE; Carethers JM
    Cancer Biol Ther; 2007 Aug; 6(8):1313-7. PubMed ID: 18059158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
    Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
    Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells.
    Dixon KM; Lui GY; Kovacevic Z; Zhang D; Yao M; Chen Z; Dong Q; Assinder SJ; Richardson DR
    Br J Cancer; 2013 Feb; 108(2):409-19. PubMed ID: 23287991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein signaling inhibits hair follicle anagen induction by restricting epithelial stem/progenitor cell activation and expansion.
    Zhang J; He XC; Tong WG; Johnson T; Wiedemann LM; Mishina Y; Feng JQ; Li L
    Stem Cells; 2006 Dec; 24(12):2826-39. PubMed ID: 16960130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP7-induced-Pten inhibits Akt and prevents renal fibrosis.
    Higgins DF; Ewart LM; Masterson E; Tennant S; Grebnev G; Prunotto M; Pomposiello S; Conde-Knape K; Martin FM; Godson C
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3095-3104. PubMed ID: 28923783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation.
    Ghosh-Choudhury N; Mandal CC; Choudhury GG
    J Biol Chem; 2007 Feb; 282(7):4983-4993. PubMed ID: 17179158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel bone morphogenetic protein signaling in heterotypic cell interactions in prostate cancer.
    Yang S; Pham LK; Liao CP; Frenkel B; Reddi AH; Roy-Burman P
    Cancer Res; 2008 Jan; 68(1):198-205. PubMed ID: 18172312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.
    Morrissey C; Brown LG; Pitts TE; Vessella RL; Corey E
    Neoplasia; 2010 Feb; 12(2):192-205. PubMed ID: 20126477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.